Indeed, several of the compounds reduced EpCAM-mediated cyclin D1 (CCND1) expression in colorectal carcinoma cell line HCT-8; however, they have yet to be tested against tumor growth [118]. The gene discussed is CCND1; the disease is neoplasm.